<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): September 17, 2008</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>HEARTWARE LIMITED<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>State of Victoria, Australia</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>000-52595</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>98-0498958</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Level 57<BR>MLC Centre<BR>19-29 Martin Place<BR>Sydney NSW 2000<BR>Australia<BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>2 9238 2064</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#254;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;7.01 Regulation&nbsp;FD Disclosure</B>


<P align="left" style="font-size: 10pt">On September&nbsp;17, 2008, via an Australian Securities Exchange (&#147;ASX&#148;) announcement, the Directors of HeartWare Limited
(the &#147;Company&#148;) announced that they have received approval from the Australian Federal Court to convene meetings of the
Company&#146;s shareholders, optionholders and performance rights holders (collectively the &#147;Security Holders&#148;) to vote on
the proposed redomiciliation of the HeartWare Group from Australia to the United States of America (the &#147;Proposed
Transaction&#148;) as previously announced by the Company.


<P align="left" style="font-size: 10pt">Details of the implementation of the Proposed Transaction and meeting times are included in the ASX announcement
attached.


<P align="left" style="font-size: 10pt">An Information Memorandum containing details of the schemes of arrangement and other important information for Security
Holders, including an Independent Expert&#146;s Report, tax implications of the Proposed Transaction and details of the
resolution to be proposed at the Extraordinary General Meeting will be mailed to Security Holders on or about
September&nbsp;22, 2008.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;8.01 Other Material Events</B>


<P align="left" style="font-size: 10pt">As noted above, on September&nbsp;17, 2008 the Company announced receipt of approval from the Australian Federal Court to
convene meetings of the Company&#146;s Security Holders to vote on the proposed redomiciliation of the HeartWare Group from
Australia to the United States of America as previously announced by the Company.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits</B>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">99.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>HeartWare Limited ASX Announcement dated September&nbsp;17, 2008</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.



<P align="left" style="margin-left:46%; font-size: 10pt">HeartWare Limited


<P align="left" style="font-size: 10pt">Date: September&nbsp;17, 2008



<P align="left" style="margin-left:46%; font-size: 10pt; margin-top: -11pt">By: <U><B>/</B>s/ David McIntyre&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
<BR>
Name: David McIntyre
<BR>
Title: Chief Financial Officer


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c75370e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 7671}]
{"company-data": {"conformed-name": "HeartWare LTD", "cik": "0001389072", "assigned-sic": "3841", "irs-number": "980498958", "state-of-incorporation": "C3", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52595", "film-number": "081076197"}, "business-address": {"street1": "3351 EXECUTIVE WAY", "city": "MIRAMAR", "state": "FL", "zip": "33025", "phone": "954-874-1400"}, "mail-address": {"street1": "3351 EXECUTIVE WAY", "city": "MIRAMAR", "state": "FL", "zip": "33025"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 17, 2008
HEARTWARE LIMITED
(Exact name of registrant as specified in its charter)
State of Victoria, Australia
000-52595
98-0498958
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
Level 57
MLC Centre
19-29 Martin Place
Sydney NSW 2000
Australia
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
2 9238 2064
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
þ
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure
On September 17, 2008, via an Australian Securities Exchange ("ASX") announcement, the Directors of HeartWare Limited
(the "Company") announced that they have received approval from the Australian Federal Court to convene meetings of the
Company's shareholders, optionholders and performance rights holders (collectively the "Security Holders") to vote on
the proposed redomiciliation of the HeartWare Group from Australia to the United States of America (the "Proposed
Transaction") as previously announced by the Company.
Details of the implementation of the Proposed Transaction and meeting times are included in the ASX announcement
attached.
An Information Memorandum containing details of the schemes of arrangement and other important information for Security
Holders, including an Independent Expert's Report, tax implications of the Proposed Transaction and details of the
resolution to be proposed at the Extraordinary General Meeting will be mailed to Security Holders on or about
September 22, 2008.
Item 8.01 Other Material Events
As noted above, on September 17, 2008 the Company announced receipt of approval from the Australian Federal Court to
convene meetings of the Company's Security Holders to vote on the proposed redomiciliation of the HeartWare Group from
Australia to the United States of America as previously announced by the Company.
Item 9.01 Financial Statements and Exhibits
(d)
Exhibits
99.1
HeartWare Limited ASX Announcement dated September 17, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
HeartWare Limited
Date: September 17, 2008
By:
/
s/ David McIntyre
Name: David McIntyre
Title: Chief Financial Officer